<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17-vaccines-07-00074">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Frost</surname>
    <given-names>S.D.W.</given-names>
   </name>
   <name>
    <surname>Wrin</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Kosakovsky Pond</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Paxinos</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Chappey</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Galovich</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Beauchaine</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Petropoulos</surname>
    <given-names>C.J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2005</year>
  <volume>102</volume>
  <fpage>18514</fpage>
  <lpage>18519</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.0504658102</pub-id>
  <pub-id pub-id-type="pmid">16339909</pub-id>
 </element-citation>
</ref>
